Treatment of Leukemia and Lymphoma by Scheinberg, David A.; Jurcic, Joseph G.;

Physiology and Pharmacology

Sorozatcím: Advances in Pharmacology; 51;

10% KEDVEZMÉNY?
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.

Kiadói listaár EUR 205.00
Az ár azért becsült, mert a rendelés pillanatában nem lehet pontosan tudni, hogy a beérkezéskor milyen lesz a forint árfolyama az adott termék eredeti devizájához képest. Ha a forint romlana, kissé többet, ha javulna, kissé kevesebbet kell majd fizetnie.

85 023 Ft (80 975 Ft + 5% áfa)
Kedvezmény(ek) 10% (cc. 8 502 Ft off)
Kedvezményes ár 76 521 Ft (72 878 Ft + 5% áfa)

85 023 Ft

Beszerezhetőség

Megjelenése törölve vagy kivonva a forgalomból. Sajnos nem rendelhető.

A termék adatai:

Kiadó Elsevier Science
Megjelenés dátuma 2004. október 30.

ISBN 9780120329526
Kötéstípus Keménykötés
Terjedelem384 oldal
Méret 228x152 mm
Súly 770 g
Nyelv angol

Kategóriák

Biokémia Immunológia, allergológia Pathológia Farmakológia, terapeutika, toxikológia Gyógyszerészet Endokrinológia, diabetológia Onkológia, daganatok Biofizika

Hosszú leírás:

New Treatments of Leukemia and Lymphoma describes the most important advances in the therapy of hematopoietic cancers that have been derived from recent discoveries in cancer cell biology, kinase biochemistry, and immunology. Detailed descriptions of the large number of new and effective agents that have recently become available for the treatment of leukemias and lymphomas as well as an understanding of their mechanisms of action and their integration into current therapy are provided. A number of experimental drug reagents currently in clinical investigation are also discussed. The therapies include conventional anti-metabolites, monoclonal antibodies directed to cell surface receptors, antibodies tagged with toxins and radiopharmaceuticals, inhibitors of specific kinases, stem cell transplants, and engineered T-cells designed to selectively target hematopoietic cancers. The contents of the book will allow practitioners and investigators alike to understand what is current and state of the art as well as what to look for in the future.

Több

Tartalomjegyzék:

Kinase Inhibitors in Leukemia
State of the Art Treatment of APL
Investigational Agents in Myeloid Disorders
Methodologic Issues in Investigation of Targeted Therapies in AML
Purine Analogues in Leukemia
Monoclonal Antibody Therapy in Lymphoid Leukemias
Native Antibody and Antibody-Targeted Chemotherapy for Acute Myeloid Leukemia
Radioimmunotherapy of Leukemia
Immunotoxins and Toxin Constructs in Leukemia/Lymphoma
Antibody Therapy of Lymphoma
Vaccines in Leukemia
Therapeutic Idiotype Vaccines for Non-Hodgkin's Lymphoma
Cytokine Modulation of the Innate Immune System in the Treatment of Leukemia and Lymphoma
Donor Lymphocyte Infusions
Somatic Cell Engineering and the Immunotherapy of Leukemias and Lymphomas